Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Thatcher

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Cancer|May 2, 2006
Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancerRichard Booton, Tim Ward, Jim Heighway, et al.
International Journal of Cancer|July 19, 2002
Effect of O6-(4-bromothenyl)guanine on different temozolomide schedules in a human melanoma xenograft modelMark R Middleton, Nicholas Thatcher, T Brian H McMurry, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2011
Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trialHamid Sheikh, Rovel Colaco, Paul Lorigan, et al.
Current Medical Research and Opinion|April 17, 2010
Observation of the treatment and outcomes of patients receiving chemotherapy for advanced NSCLC in Europe (ACTION study)Helge G Bischoff, Ben van den Borne, Francisco L Pimentel, et al.
The Oncologist|August 15, 2009
Expert consensus on the management of erlotinib-associated cutaneous toxicity in the u.kNicholas Thatcher, Marianne Nicolson, Richard W Groves, et al.
European Journal of Clinical Investigation|May 22, 2015
The diagnosis and management of inpatient hyponatraemia and SIADHPaul Grant, John Ayuk, Pierre-Marc Bouloux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trialNicholas Thatcher, Wendi Qian, Peter I Clark, et al.
Oncology|April 28, 2005
Standard of care for cancer-related anemia: improving hemoglobin levels and quality of lifeEnrico Cortesi, Pere Gascón, David Henry, et al.
Lung Cancer (Amsterdam, Netherlands)|October 22, 2011
Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trialRovel Colaco, Hamid Sheikh, Paul Lorigan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2019
Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III StudyNicholas Thatcher, Jerome H Goldschmidt, Michael Thomas, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cancer|May 2, 2006
Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancerRichard Booton, Tim Ward, Jim Heighway, et al.
International Journal of Cancer|July 19, 2002
Effect of O6-(4-bromothenyl)guanine on different temozolomide schedules in a human melanoma xenograft modelMark R Middleton, Nicholas Thatcher, T Brian H McMurry, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2011
Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trialHamid Sheikh, Rovel Colaco, Paul Lorigan, et al.
Current Medical Research and Opinion|April 17, 2010
Observation of the treatment and outcomes of patients receiving chemotherapy for advanced NSCLC in Europe (ACTION study)Helge G Bischoff, Ben van den Borne, Francisco L Pimentel, et al.
The Oncologist|August 15, 2009
Expert consensus on the management of erlotinib-associated cutaneous toxicity in the u.kNicholas Thatcher, Marianne Nicolson, Richard W Groves, et al.
European Journal of Clinical Investigation|May 22, 2015
The diagnosis and management of inpatient hyponatraemia and SIADHPaul Grant, John Ayuk, Pierre-Marc Bouloux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trialNicholas Thatcher, Wendi Qian, Peter I Clark, et al.
Oncology|April 28, 2005
Standard of care for cancer-related anemia: improving hemoglobin levels and quality of lifeEnrico Cortesi, Pere Gascón, David Henry, et al.
Lung Cancer (Amsterdam, Netherlands)|October 22, 2011
Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trialRovel Colaco, Hamid Sheikh, Paul Lorigan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2019
Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III StudyNicholas Thatcher, Jerome H Goldschmidt, Michael Thomas, et al.
Pageof 4